SMITH ASSET MANAGEMENT GROUP LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,0000.0%1200.0%0.00%
Q1 2021$2,000
-97.5%
120
-96.8%
0.00%
-100.0%
Q4 2020$79,000
+43.6%
3,7200.0%0.01%
+66.7%
Q3 2020$55,000
+34.1%
3,720
+32.4%
0.00%
+50.0%
Q2 2020$41,000
+24.2%
2,810
-1.1%
0.00%0.0%
Q1 2020$33,000
-50.7%
2,8400.0%0.00%
-33.3%
Q4 2019$67,000
+26.4%
2,8400.0%0.00%
+50.0%
Q3 2019$53,000
+23.3%
2,840
+22.9%
0.00%
+100.0%
Q2 2019$43,000
-23.2%
2,3100.0%0.00%
-50.0%
Q1 2019$56,000
-75.8%
2,310
-74.1%
0.00%
-75.0%
Q4 2018$231,000
-18.1%
8,9100.0%0.01%0.0%
Q3 2018$282,0008,9100.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders